Trial intelligence / Profile preview

Polyethylene Glycol Versus Low Volume Solutions Prior to Colonoscopy

NCT02956057Phase 4Completed

Sponsor
Tomas Bata Hospital
Start
Nov 2016
Primary completion
May 2017
Modality
Implantable Devices, Transdermal Patches, Inhalation Devices
Countries
1
01

Overview

Phase 4, randomised, open-label trial of sodium picosulfate + magnesium oxide + citric acid and polyethylene glycol plus ascorbate in colonoscopy (6 arms), sponsored by Tomas Bata Hospital. Primary endpoint: Quality of Bowel Preparation Using the Aronchick Scale at 1 day. Started Nov 2016; status: completed.

02

Drugs

sodium picosulfate + magnesium oxide + citric acidpolyethylene glycol plus ascorbate
03

Conditions

colonoscopy

Beyond the preview

Go deeper on NCT02956057.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02956057.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call